Nootropic activity of acetaminophen against colchicine induced cognitive impairment in rats

Journal of Clinical Biochemistry and Nutrition

Volumn 50, Issue 3, 2012, Pages 241-244

  Pitchaimani, Vigneshwaran ^a   Arumugam, Somasundaram ^a,b   Thandavarayan, Rajarajan A ^b   Thiyagarajan, Manisenthilkumar K ^a   Aiyalu, Rajasekaran ^a   Sreedhar, Remya ^c   Nakamura, Takashi ^b   Watanabe, Kenichi ^b  

^a KMCH COLLEGE OF PHARMACY   (India)

^b NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^c Kamla Nehru College of Pharmacy   (India)

Author keywords

Acetaminophen; Alzheimer's disease; Colchicine; Learning and memory

Indexed keywords

ACETYLCHOLINESTERASE; CATALASE; COLCHICINE; GLUTATHIONE; MALONALDEHYDE; PARACETAMOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN HOMOGENATE; COGNITION; COGNITIVE DEFECT; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; MEMORY; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; RAT;

CAENORHABDITIS ELEGANS; RATTUS; RATTUS NORVEGICUS;

EID: 84860742364     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.11-73     Document Type: Article

References (25)

1. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-356. (Pubitemid 34790756)
2. Perry G, Cash DA, Smith MA. Alzheimer disease and oxidative stress. J Biomed Biotechnol 2002; 2: 120-123. (Pubitemid 44204507)
3. Mohandas E, Rajmohan V, Raghunath B. Neurobiology of Alzheimer's disease. Indian J Psychaitry 2009; 51: 55-61.
4. Veerendra Kumar MH, Gupta YK. Intracerebroventricular administration of colchicine produces cognitive impairment associated with oxidative stress in rats. Pharmacol Biochem Behav 2002; 73: 565-571. (Pubitemid 34879162)
5. Nakayama T, Sawada T. Involvement of microtubule integrity in memory impairment caused by colchicine. Pharmacol Biochem Behav 2002; 71: 119-138. (Pubitemid 34102471)
6. Nakagawa Y, Nakamura S, Kaśe Y, Noguchi T, Ishihara T. Colchicine lesions in the rat hippocampus mimic the alterations of several markers in Alzheimer's disease. Brain Res 1987; 408: 57-64. (Pubitemid 17068416)
7. Bisaglia M, Venezia V, Piccioli P, et al. Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid beta-peptides induced oxidative stress and reduces NF-kappaB activation. Neurochem Int 2002; 41: 43-54. (Pubitemid 34251405)
8. Maharaj H, Maharaj DS, Daya S. Acetylsalicylic acid and acetaminophen protect against oxidative neurotoxicity. Metab Brain Dis 2006; 21: 189-199.
9. Locke CJ, Fox SA, Caldwell GA, Caldwell KA. Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease. Neurosci Lett 2008; 439: 129-133.
10. Tripathy D, Grammas P. Acetaminophen protects brain endothelial cells against oxidative stress. Microvasc Res 2009; 77: 289-296.
11. Aebi H. Catalase. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis, Vol. II, Academic Press, New York, 1974; 673-678.
12. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77.
13. Ellman GL, Courtney KD, Andres V Jr., Feather-stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95.
14. Wills ED. Mechanism of lipid peroxide formation in animal tissues. Biochem J 1996; 99: 667-676.
15. Wang Y, Liu J, Zhang Z, Bi P, Qi Z, Zhang C. Anti-neuroinflammation effect of ginsenoside Rbl in a rat model of Alzheimer disease. Neurosci Lett 2011; 487: 70-72.
16. Di Stefano A, Sozio P, Cerasa LS, et al. Ibuprofen and lipoic acid diamide as co-drug with neuroprotective activity: pharmacological properties and effects in beta-amyloid (1-40) infused Alzheimer's disease rat model. Int J Immunopathol Pharmacol 2010; 23: 589-599.
17. Kumar A, Seghal N, Venketeshwara SP, Sreenivaslu PN. Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine-induced dysfunction and oxidative stress in rat. Eur J Pharmacol 2006; 551: 58-66. (Pubitemid 44648058)
18. Chibnall JT, Tait RC, Harman B, Luebbert RA. Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-to-severe dementia. J Am Geriatr Soc 2005; 53: 1921-1929. (Pubitemid 41826069)
19. Husebo BS, Ballard C, Sandvik R, Nilsen OB, Aarsland D. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ 2011; 343: d4065.
20. Elliott AF, Horgas AL. Effects of an analgesic trial in reducing pain behaviors in community-dwelling older adults with dementia. Nurs Res 2009; 58: 140-145.
21. Landolfi C, Soldo L, Polenzani L, et al. Inflammatory molecule release by beta-amyloid-treated T98G astrocytoma cells: role of prostaglandins and modulation by paracetamol. Eur J Pharmacol 1998; 360: 55-64. (Pubitemid 28529397)
22. Ishida T, Sato T, Irifune M, Tanaka K, Nakamura N, Nishikawa T. Effect of acetaminophen, a cyclooxygenase inhibitor, on Morris water maze task performance in mice. J Psychopharmacol 2007; 21: 757-767. (Pubitemid 47437916)
23. Ye MX, Li JL. Acetaminophen and neural degeneration: is there a possible link? Med Hypotheses 2010; 74: 390-391.
24. Milton NG. Inhibition of catalase activity with 3-amino-triazole enhanced the cytotoxicity of Alzheimer's amyloid-beta peptide. Neurotoxicology 2001; 22: 767-774. (Pubitemid 34075634)
25. Lores Arnaiz S, Llesuy S, Cutrín JC, Boveris A. Oxidative stress by acute acetaminophen administration in mouse liver. Free Radic Biol Med 1995; 19: 303-310.